Table 3:
Comparison between with PHT and
without PHT as regards to aboratory parameters.
|
Parameters |
Patients without PHT |
Patients with PHT |
P |
|
Duration of CKD (months) |
18.13 ± 7 |
57.7 ± 41 |
< 0.001 |
|
Duration of hemodialysis (months) |
19.8 ± 8 |
60 ± 40 |
< 0.001 |
|
Duration of AVF (months) |
23 ± 14 |
57.4 ± 40 |
< 0.001 |
|
Body mass index |
28.8 ± 6.2 |
26.4 ± 4.9 |
> 0.05 |
|
Systolic blood pressure (mmHg) |
133 ± 18 |
137 ± 16 |
> 0.05 |
|
Diastolic blood pressure (mmHg0 |
82 ± 7 |
84 ± 7 |
> 0.05 |
|
Heart rate (
beat /min) |
84 ± 6.8 |
90 ± 9.8 |
< 0.05 |
|
Serum creatinine (mg/dl) |
5.2 ± 2.6 |
6.6 ± 2.4 |
> 0.001 |
|
Blood urea (mg/dl) |
120 ± 38 |
140 ± 48 |
> 0.001 |
|
eGFR (ml/min) |
26 ± 5.4 |
22.9 ± 4.8 |
> 0.05 |
|
KT/V |
1.45 ± 0.13 |
1.44 ± 0.18 |
> 0.05 |
|
Serum calcium
(mg/dl) |
8.7 ± 1 |
8.6 ± 0.67 |
> 0.05 |
|
Serum phosphorus
(mg/dl) |
5.30 ± 1.1 |
6.0 ± 0.9 |
< 0.005 |
|
Parathyroid hormone ( pg/ml) |
270 ± 226 |
384 ± 216 |
> 0.05 |
|
Hemoglobin levels (g/dl) |
11.4 ± 1 |
10.4 ± 1.1 |
< 0.005 |
|
Serum uric acid
(mg/dl) |
6.7 ± 1.4 |
6.6 ± 1.7 |
> 0.05 |
|
Serum albumin (g/dl) |
3.8 ± 0.6 |
3.8 ± 0.7 |
> 0.05 |
|
Random blood glucose (mg/dl) |
115 ± 15 |
116 ± 23 |
> 0.05 |
|
Cholesterol (mg/dl) |
219 ± 23 |
207 ± 23 |
> 0.05 |
|
Triglycerides (mg/dl) |
150 ± 29 |
147 ± 48 |
> 0.05 |
|
LDL (mg/dl) |
111 ± 14 |
112 ± 17 |
> 0.05 |
|
Left ventricular end diastolic dimension (mm) |
4.60 ± 0.4 |
5.55 ± 0.8 |
< 0.001 |
|
Left ventricular end systolic dimension (mm) |
3.0 ± 0.4 |
4.13 ± 0.8 |
< 0.001 |
|
Ejection fraction % |
67.2 ± 4.1 |
63.1 ± 6.7 |
< 0.05 |
|
Fractional shortening % |
37.16 ± 2.4 |
34.88 ± 3.8 |
< 0.05 |
|
Left atrial dimension ( mm) |
3.73 ± 0.53 |
4.50 ± 0.65 |
< 0.001 |
|
cardiac output (ml/min) |
6607 ± 1031 |
7607 ± 996 |
< 0.001 |
|
Pulmonary artery pressure( mmHg) |
30 ± 3 |
47 ± 8 |
< 0.001 |
|
AVF blood flow (ml/min) |
840.7 ± 154 |
1228 ± 238 |
< 0.001 |